• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-取代(二苯并[b,d]噻吩-4-基)-2-吗啉-4H-色烯-4-ones,具有双重 DNA-PK/PI3-K 抑制活性。

1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity.

机构信息

Newcastle Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom.

出版信息

J Med Chem. 2013 Aug 22;56(16):6386-401. doi: 10.1021/jm400915j. Epub 2013 Aug 1.

DOI:10.1021/jm400915j
PMID:23855836
Abstract

Analogues of (dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one (NU7441), a potent inhibitor of DNA-dependent protein kinase (DNA-PK; IC50 = 42 ± 2 nM), have been synthesized in which water-solubilizing groups [NHCO(CH₂)nNR¹R², where n = 1 or 2 and the moiety R¹R²N was derived from a library of primary and secondary amines, e.g., morpholine] were placed at the 1-position. Several of the newly synthesized compounds exhibited high potency against DNA-PK and potentiated the cytotoxicity of ionizing radiation (IR) in vitro 10-fold or more (e.g., 2-(4-ethylpiperazin-1-yl)-N-(4-(2-morpholino-4-oxo-4H-chromen-8-yl)dibenzo[b,d]thio-phen-1-yl)acetamide, 39; DNA-PK IC₅₀ = 5.0 ± 1 nM, IR dose modification ratio = 13). Furthermore, 39 was shown to potentiate not only IR in vitro but also DNA-inducing cytotoxic anticancer agents, both in vitro and in vivo. Counter-screening against other members of the phosphatidylinositol 3-kinase (PI-3K) related kinase (PIKK) family unexpectedly revealed that some of the compounds were potent mixed DNA-PK and PI-3K inhibitors.

摘要

(二苯并[b,d]噻吩-4-基)-2-吗啉代-4H-色烯-4-酮(NU7441)类似物是一种有效的 DNA 依赖性蛋白激酶(DNA-PK;IC50=42±2nM)抑制剂,其在 1 位上引入了水溶性基团[NHCO(CH₂)nNR¹R²,其中 n=1 或 2,基团 R¹R²N 来源于伯胺和仲胺库,例如吗啉]。新合成的几种化合物对 DNA-PK 表现出高活性,并在体外将电离辐射(IR)的细胞毒性增强 10 倍或更多(例如,2-(4-乙基哌嗪-1-基)-N-(4-(2-吗啉代-4-氧代-4H-色烯-8-基)二苯并[b,d]噻吩-1-基)乙酰基)酰胺,39;DNA-PK IC₅₀=5.0±1nM,IR 剂量修饰比=13)。此外,39 不仅能增强体外的 IR,还能增强体外和体内的 DNA 诱导细胞毒性抗癌剂。针对磷酸肌醇 3-激酶(PI3K)相关激酶(PIKK)家族其他成员的反向筛选出人意料地发现,一些化合物是有效的 DNA-PK 和 PI3K 混合抑制剂。

相似文献

1
1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity.1-取代(二苯并[b,d]噻吩-4-基)-2-吗啉-4H-色烯-4-ones,具有双重 DNA-PK/PI3-K 抑制活性。
J Med Chem. 2013 Aug 22;56(16):6386-401. doi: 10.1021/jm400915j. Epub 2013 Aug 1.
2
DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.DNA 依赖性蛋白激酶(DNA-PK)抑制剂。色烯-4-酮化学型的喹啉-4-酮和吡啶并嘧啶-4-酮替代物的合成和生物活性。
J Med Chem. 2010 Dec 23;53(24):8498-507. doi: 10.1021/jm100608j. Epub 2010 Nov 16.
3
Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives.具有对映选择性的稠合色酮衍生物对 DNA 依赖性蛋白激酶(DNA-PK)的强效抑制作用。
Org Biomol Chem. 2012 Sep 7;10(33):6747-57. doi: 10.1039/c2ob26035b. Epub 2012 Jul 19.
4
Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach.采用小分子文库方法发现DNA依赖性蛋白激酶(DNA-PK)的强效色满-4-酮抑制剂。
J Med Chem. 2005 Dec 1;48(24):7829-46. doi: 10.1021/jm050444b.
5
Atropisomeric 8-arylchromen-4-ones exhibit enantioselective inhibition of the DNA-dependent protein kinase (DNA-PK).对映异构 8-芳基色烯-4-ones 表现出对 DNA 依赖性蛋白激酶(DNA-PK)的对映选择性抑制。
Org Biomol Chem. 2010 Apr 21;8(8):1922-8. doi: 10.1039/b926245h.
6
Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione.线性 5、6 和 10 取代-2-吗啉基-色满-氧氮杂二酮和角型 3、4、6 取代-8-吗啉基-色满-氧氮杂二酮-2、10-二酮的合成、结构阐明、DNA-PK、PI3K、抗血小板和抗菌活性。
J Enzyme Inhib Med Chem. 2016;31(sup2):86-95. doi: 10.1080/14756366.2016.1190710. Epub 2016 Jun 2.
7
Judicious application of allyl protecting groups for the synthesis of 2-morpholin-4-yl-4-oxo-4H-chromen-8-yl triflate, a key precursor of DNA-dependent protein kinase inhibitors.烯丙基保护基在2-吗啉-4-基-4-氧代-4H-色烯-8-基三氟甲磺酸酯合成中的明智应用,DNA依赖性蛋白激酶抑制剂的关键前体。
Org Lett. 2006 Dec 21;8(26):5927-9. doi: 10.1021/ol062297x.
8
Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.磷脂酰肌醇3-激酶相关激酶的吡喃酮、硫代吡喃酮和吡啶酮抑制剂。DNA依赖性蛋白激酶抑制的构效关系,以及共济失调毛细血管扩张症突变激酶的首个强效和选择性抑制剂的鉴定。
J Med Chem. 2007 Apr 19;50(8):1958-72. doi: 10.1021/jm061121y. Epub 2007 Mar 20.
9
Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro.DNA依赖性蛋白激酶的选择性苯并吡喃酮和嘧啶并[2,1-a]异喹啉-4-酮抑制剂:合成、构效关系研究及对人肿瘤细胞系的体外放射增敏作用
J Med Chem. 2005 Jan 27;48(2):569-85. doi: 10.1021/jm049526a.
10
DNA-dependent protein kinase (DNA-PK) inhibitors: structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain.DNA 依赖性蛋白激酶 (DNA-PK) 抑制剂:ATP 结合域的 O-烷氧基苯色烯-4-酮探针的结构-活性关系。
Bioorg Med Chem Lett. 2011 Feb 1;21(3):966-70. doi: 10.1016/j.bmcl.2010.12.047. Epub 2010 Dec 13.

引用本文的文献

1
Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics.作为潜在癌症治疗药物的ATM、ATR和DNA-PK抑制剂的药物化学突破。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2489720. doi: 10.1080/14756366.2025.2489720. Epub 2025 Apr 21.
2
Identification of 6-Anilino Imidazo[4,5-]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers.鉴定 6-苯胺咪唑并[4,5-]吡啶-2-酮类化合物作为选择性的 DNA 依赖性蛋白激酶抑制剂及其作为放射增敏剂的应用。
J Med Chem. 2024 Jul 25;67(14):12366-12385. doi: 10.1021/acs.jmedchem.4c01120. Epub 2024 Jul 15.
3
Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq.
利用 DISCOVER-Seq 提高体内 CRISPR 脱靶检测的灵敏度。
Nat Methods. 2023 May;20(5):706-713. doi: 10.1038/s41592-023-01840-z. Epub 2023 Apr 6.
4
Cycloaddition of 4-Acyl-1-pyrrole-2,3-diones Fused at []-Side and Cyanamides: Divergent Approach to 4-1,3-Oxazines.[ ]-并环 4-酰基-1-吡咯-2,3-二酮与氰酰胺的环加成反应:4-1,3-恶嗪的多样化方法。
Molecules. 2022 Aug 17;27(16):5257. doi: 10.3390/molecules27165257.
5
NHC-Ni(II)-catalyzed cyclopropene-isocyanide [5 + 1] benzannulation.国家卫生健康委员会-镍(II)催化的环丙烯-异腈[5 + 1]苯并环化反应
Nat Commun. 2022 Jul 16;13(1):4145. doi: 10.1038/s41467-022-31896-y.
6
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.DNA 依赖性蛋白激酶抑制剂的发展与演进及其在癌症治疗中的应用。
Int J Mol Sci. 2022 Apr 12;23(8):4264. doi: 10.3390/ijms23084264.
7
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development.多种 DNA 损伤反应抑制剂的放射增敏作用分析,用于早期临床开发。
Mol Cancer Ther. 2021 Sep;20(9):1614-1626. doi: 10.1158/1535-7163.MCT-20-0502. Epub 2021 Jun 22.
8
Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy.预防损伤限制:靶向DNA依赖蛋白激酶催化亚基(DNA-PKcs)和DNA双链断裂修复途径用于卵巢癌治疗
Front Oncol. 2015 Oct 26;5:240. doi: 10.3389/fonc.2015.00240. eCollection 2015.